Sun Pharma’s Q2 results show consistent performance across domestic and global markets
Sun Pharma’s Q2 results highlight steady operational growth with ₹14,478 crore revenue, 8% YoY rise, and improved profitability driven by strong specialty and generics portfolios across geographies.